102 related articles for article (PubMed ID: 25691725)
1. Session 1.5: other viral clearance and inactivation approaches (multimodal chromatography, membrane chromatography, chemical precipitation).
Hubbard B
PDA J Pharm Sci Technol; 2015; 69(1):173-82. PubMed ID: 25691725
[No Abstract] [Full Text] [Related]
2. Viral clearance using traditional, well-understood unit operations: session 1.2. Anion exchange chromatography; and session 1.3. Protein a chromatography.
Roush D
PDA J Pharm Sci Technol; 2015; 69(1):154-62. PubMed ID: 25691723
[No Abstract] [Full Text] [Related]
3. Session 2/3: integrated viral clearance strategy and case studies.
Willkommen H
PDA J Pharm Sci Technol; 2015; 69(1):183-94. PubMed ID: 25691726
[No Abstract] [Full Text] [Related]
4. Session 4: overall integrated viral clearance and adventitious agents strategy.
Blümel J; Tounekti O
PDA J Pharm Sci Technol; 2015; 69(1):195-205. PubMed ID: 25691727
[No Abstract] [Full Text] [Related]
5. The application of caprylic acid in downstream processing of monoclonal antibodies.
Li Y
Protein Expr Purif; 2019 Jan; 153():92-96. PubMed ID: 30205153
[TBL] [Abstract][Full Text] [Related]
6. 2013 viral clearance symposia - session 5. Conference summary: key discussion and outcomes, pending questions, and proposed experiments.
Blümel J; Roush D
PDA J Pharm Sci Technol; 2015; 69(1):206-10. PubMed ID: 25691728
[No Abstract] [Full Text] [Related]
7. Multiple functions of caprylic acid-induced impurity precipitation for process intensification in monoclonal antibody purification.
Trapp A; Faude A; Hörold N; Schubert S; Faust S; Grob T; Schmidt S
J Biotechnol; 2018 Aug; 279():13-21. PubMed ID: 29729310
[TBL] [Abstract][Full Text] [Related]
8. [Synthesis and photochemical virus inactivation of novel phenothiazines].
Wen H; Wang XF; Huang Y; Wang JX; Yang GZ
Yao Xue Xue Bao; 2010 Jan; 45(1):72-6. PubMed ID: 21351453
[TBL] [Abstract][Full Text] [Related]
9. Mefenamic acid in combination with ribavirin shows significant effects in reducing chikungunya virus infection in vitro and in vivo.
Rothan HA; Bahrani H; Abdulrahman AY; Mohamed Z; Teoh TC; Othman S; Rashid NN; Rahman NA; Yusof R
Antiviral Res; 2016 Mar; 127():50-6. PubMed ID: 26794398
[TBL] [Abstract][Full Text] [Related]
10. Proceedings of the 2009 Viral Clearance Symposium.
Miesegaes G; Bailey M; Willkommen H; Chen Q; Roush D; Blümel J; Brorson K
Dev Biol (Basel); 2010; 133():3-101. PubMed ID: 21516942
[TBL] [Abstract][Full Text] [Related]
11. Viral clearance of traditional unit operations: virus-retentive filtration.
Chen Q; Chen D
PDA J Pharm Sci Technol; 2015; 69(1):142-53. PubMed ID: 25691722
[No Abstract] [Full Text] [Related]
12. Butyroyl-arginine as a potent virus inactivation agent.
Katsuyama Y; Yamasaki H; Tsujimoto K; Koyama AH; Ejima D; Arakawa T
Int J Pharm; 2008 Sep; 361(1-2):92-8. PubMed ID: 18617337
[TBL] [Abstract][Full Text] [Related]
13. Inactivation of a non-enveloped RNA virus by artificial ribonucleases: honey bees and acute bee paralysis virus as a new experimental model for in vivo antiviral activity assessment.
Fedorova AA; Azzami K; Ryabchikova EI; Spitsyna YE; Silnikov VN; Ritter W; Gross HJ; Tautz J; Vlassov VV; Beier H; Zenkova MA
Antiviral Res; 2011 Sep; 91(3):267-77. PubMed ID: 21722669
[TBL] [Abstract][Full Text] [Related]
14. Why do some immobilized N-alkylated polyethylenimines far surpass others in inactivating influenza viruses?
Liu H; Elkin I; Chen J; Klibanov AM
Biomacromolecules; 2015 Jan; 16(1):351-6. PubMed ID: 25486335
[TBL] [Abstract][Full Text] [Related]
15. Inactivation of lipid-enveloped viruses in proteins by caprylate.
Lundblad JL; Seng RL
Vox Sang; 1991; 60(2):75-81. PubMed ID: 2031341
[TBL] [Abstract][Full Text] [Related]
16. The effect of chemical inactivation of bovine viral diarrhea virus with beta-propiolactone and binary ethyleneimine on plasma proteins and coagulation factors.
Refaie FM; Esmat AY; Mohamed AF; Mohamed WA
Egypt J Immunol; 2004; 11(2):9-20. PubMed ID: 16734113
[TBL] [Abstract][Full Text] [Related]
17. Novel amphiphilic compounds effectively inactivate the vaccinia virus.
Fedorova AA; Goncharova EP; Ryabchikova EI; Vlasov VV; Zenkova MA
FEBS Lett; 2012 Jun; 586(11):1669-73. PubMed ID: 22673577
[TBL] [Abstract][Full Text] [Related]
18. Viral Inactivation: Low pH and Detergent.
Durno L; Tounekti O
PDA J Pharm Sci Technol; 2015; 69(1):163-72. PubMed ID: 25691724
[No Abstract] [Full Text] [Related]
19. Optimization by factorial analysis of caprylic acid precipitation of non-immunoglobulins from hyperimmune equine plasma for antivenom preparation.
Nudel BC; Perdoménico C; Iácono R; Cascone O
Toxicon; 2012 Jan; 59(1):68-73. PubMed ID: 22079738
[TBL] [Abstract][Full Text] [Related]
20. QSRR: quantitative structure-(chromatographic) retention relationships.
Kaliszan R
Chem Rev; 2007 Jul; 107(7):3212-46. PubMed ID: 17595149
[No Abstract] [Full Text] [Related]
[Next] [New Search]
